135 related articles for article (PubMed ID: 15665796)
1. The approach to small vessels in the era of drug-eluting stents.
Holmes DR; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S31-7. PubMed ID: 15665796
[TBL] [Abstract][Full Text] [Related]
2. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
4. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of drug-eluting stents.
Williams DO; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
7. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
Mauri L; Orav EJ; Candia SC; Cutlip DE; Kuntz RE
Circulation; 2005 Nov; 112(18):2833-9. PubMed ID: 16267256
[TBL] [Abstract][Full Text] [Related]
8. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
Ryan J; Cohen DJ; Pinto DS
Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents.
Kereiakes DJ; Young JJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798
[TBL] [Abstract][Full Text] [Related]
12. The role of BMS in the drug eluting stent era: is still there any place for them?
Fineschi M; Gori T
Catheter Cardiovasc Interv; 2006 Sep; 68(3):456; author reply 457. PubMed ID: 16892446
[No Abstract] [Full Text] [Related]
13. Xience V everolimus-eluting coronary stent.
Kukreja N; Onuma Y; Serruys PW
Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents: clinical perspectives on drug and design differences.
Rogers CD
Rev Cardiovasc Med; 2005; 6 Suppl 1():S3-12. PubMed ID: 15665795
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
17. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
[TBL] [Abstract][Full Text] [Related]
19. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
